Percept Is Different

Total Page:16

File Type:pdf, Size:1020Kb

Load more

percept ® is different... Australia’s most advanced and comprehensive non-invasive prenatal test perce ® cell-free DNA pt prenatal test Why percept® percept is Australia’s most comprehensive non-invasive prenatal testing (NIPT) service. Advanced bioinformatics means percept is the only NATA/RCPA accredited Australian NIPT service to assess all 24 chromosomes, (chromosomes 1-22 and the X & Y chromosomes). This means we can identify additional genetic conditions like: • rare autosomal trisomies; • large segmental genetic imbalances like deletions and duplications. These are reported as additional findings; • familial balanced translocation analysis; • all our tests are fully supported by clinical interpretation and genetic counselling at no additional cost. 1. percept ® in numbers percept includes our integrated genetic counselling Clinical utility of percept Condition Test Frequency service, so patients and 1 in 74 Conventional NIPT (21,18, 13) (based on VCGS referral data) health professionals are fully percept advanced NIPT Trisomy 21 1 in 113 Trisomy 18 1 in 420 informed and supported Trisomy 13 1 in 436 Additional analysis by percept Rare trisomies (other than 21, 18, 13) 1 in 285 (PPV 50-65%)1,2 Additional findings(dels & dups) 1 in 612 (PPV 53%) Additional high risk cases called by percept 1 in 200 (PPV 50-65%) Additional clinically relevant cases 1 in 300-400 detected by percept Compared to micro-deletion syndrome panels offered by other providers Micro-deletion syndrome panels Approx 1 in 2,100 (PPV 0-18%) 3-8 Therefore... • Our analysis pipeline detects clinically significant genetic changes that occur more frequently and with a higher positive predictive value (PPV) than micro-deletion syndromes offered through other providers. • Using a genome wide approach means genetic changes can be detected across all chromosomes and is not limited to a small number of targeted regions. • The size of the genetic change detectable is dependent on a number of quality measures which includes fetal fraction and genomic location, but on average is approximately 10 mega bases in size. 2. Explained: rare autosomal trisomies & additional findings Rare autosomal trisomies Additional findings • involve all chromosomes other than 21, 18, 13 & the • advanced bioinformatics means the entire length of every sex chromosomes; autosome is analysed, representing an analysis similar to • individually occur less frequently than 21, 18 & 13 but a traditional karyotype; collectively are as frequent as trisomy 13 or 18; • large deletions & duplications can be associated with • up to 76% of rare trisomies detected by percept are serious congenital malformations & intellectual disability; clinically relevant to the pregnancy; • test sensitivity & genomic size of detectable imbalances • rare trisomies may be associated with miscarriages, is dependent on several factors, including fetal fraction; intra-uterine growth retardation, premature labour, • important to note that a low risk NIPT result does not compromised placental function, and as live birth exclude the presence of all deletions & duplications. with serious congenital anomalies. Examples of additional findings from percept® Case report - Pallister-Killian syndrome Chromosome imbalance Condition Chromosome 2 - partial monosomy 2q 2q37 deletion syndrome A. Chromosome 3 - partial monosomy 3p 3p deletion syndrome Chromosome 4 - partial monosomy 4p Wolf-Hirschhorn syndrome Chromosome 5 - partial monosomy 5p Cri-du-chat syndrome Chromosome 9 - tetrasomy 9p Tetrasomy 9p syndrome B. A: WISECONDOR plot showing Chromosome 10 - partial monosomy 10p 16 Mb deletion increased sequence counts for the Chromosome 11 - partial monosomy 11q Jacobsen syndrome p-arm of chromosome 12 (shown Chromosome 12 - tetrasomy 12p Pallister-Killian syndrome by red line & purple block). Chromosome 15 - partial trisomy 15q 27Mb duplication Chromosome 17 - partial monosomy 17p Miller-Dieker lissencephaly syndrome B: Conventional karyotyping on Chromosome 18 - tetrasomy 18p Tetrasomy 18p syndrome amniocytes confirmed this to Chromosome 22 - partial trisomy 22q 11 Mb duplication be mosaicism for tetrasomy of Chromosome 22 - der(22)t(11;22) Emanuel syndrome chromosome 12p. Uniparental disomy post trisomy 15 NIPT Prader-Willi syndrome All confirmed by CVS or amniocentesis ® Test Features for Routine Analysis percept other providers Why percept is different... Analysis of all 24 chromosomes ✘ Screening for rare autosomal trisomies ✘# Additional findings (large segmental deletions/duplications) ✘ VCGS is a not-for-profit Discrimination of mosaicism (maternal & placental) * ✘ Translocation analysis for known carriers ** ✘ specialist genetics service; Co-twin demise ** ✘ Triplet pregnancies ** ✘ all proceeds support VCGS Key Service Features Rapid turn around time 3-5 days 4-10 days medical research Fully integrated laboratory and clinical service variable Lower limit of detection for trisomy 2.5% fetal fraction up to 4% fetal fraction Low test failure rate 0.2% up to 1-3% Full genetic data interrogation & interpretation variable Clinical support provided with all testing variable Conditions detected (n=30,000) Sensitivity PPV Trisomy 21 >99% 99% Trisomy 18 >98% >95% Trisomy 13 >99% >85% Monosomy X >95% >30%*** Other sex chromosome anomalies (XXX, XXY, XYY) LD 75-92% Fetal sex >99% >99% Rare trisomies (n=16,885)1 LD (for each) 50-65%1,2,° Additional findings (dels & dups >10Mb) (n=15,600)^ 78% 53% Known translocations (12 high risk cases/75 tests) 100% 100% # Offered by one other provider * This is not always definitive but can be used to help direct care of the pregnancy ** Prior notification required as additional clinical information is needed and sample collection may vary *** True fetal 45,X (including variants). Most causes of false positive results are confined placental mosaicism & maternal contributions (VCGS data on file) LD = limited data ° This value represents findings confirmed in the fetus & those confined to the placenta but considered clinically relevant1,2 ^ VCGS NATA validation study (2017) (VCGS data on file) 4. References 1. Pertile MD, Halks-Miller M, Flowers N, Barbacioru C, Kinnings SL, Vavrek D, et al. Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease. Sci Transl Med. 2017;9(405). 2. Pertile MD. Chapter 7 - Genome-Wide Cell-Free DNA-Based Prenatal Testing for Rare Autosomal Trisomies and Subchromosomal Abnormalities. In: Page-Christiaens L, Klein H-G, editors. Noninvasive Prenatal Testing (NIPT): Academic Press; 2018. p. 97-123. 3. Hui L. Cell-free DNA testing for 22q11.2 deletion syndrome: appraising the viability, effectiveness and appropriateness of screening. Ultrasound Obstet Gynecol. 2016;47(2):137-41. 4. Yaron Y, Jani J, Schmid M, Oepkes D. Current Status of Testing for Microdeletion Syndromes and Rare Autosomal Trisomies Using Cell-Free DNA Technology. Obstet Gynecol. 2015;126(5):1095-9. ® 5. Valderramos SG, Rao RR, Scibetta EW, Silverman NS, Han CS, Platt LD. Cell-free DNA screening in clinical practice: abnormal perce autosomal aneuploidy and microdeletion results. Am J Obstet Gynecol. 2016;215(5):626 e1- e10. cell-free DNA pt prenatal test 6. Gross SJ, Stosic M, McDonald-McGinn DM, Bassett AS, Norvez A, Dhamankar R, et al. Clinical experience with single- nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome. Ultrasound Obstet Gynecol. 2016;47(2):177-83. P) 1300 11 8247 E) [email protected] 7. Martin K, Iyengar S, Kalyan A, Lan C, Simon AL, Stosic M, et al. Clinical experience with a single-nucleotide polymorphism- based non-invasive prenatal test for five clinically significant microdeletions. Clin Genet. 2018;93(2):293-300. 8. National Library of Medicine (US). Genetics Home Reference [Internet]. Bethesda (MD). Available from: https://ghr.nlm.nih.gov/ 5..
Recommended publications
  • RARE CHROMOSOME DISORDERS the Term, ‘Rare Chromosome Disorders’, Refers to Conditions Which

    RARE CHROMOSOME DISORDERS the Term, ‘Rare Chromosome Disorders’, Refers to Conditions Which

    INFORMATION SHEET Page 1 COMPLEX LEARNING DIFFICULTIES AND DISABILITIES RESEARCH PROJECT (CLDD) RARE CHROMOSOME DISORDERS The term, ‘rare chromosome disorders’, refers to conditions which: 1. occur due to missing, duplicated or re-arranged chromosome material 2. have a low prevalence rate (thus not including chromosomal disorders such as Down syndrome). Chromosomes are structures found in the nuclei of cells in human bodies. Each chromosome contains thousands of genes which determine how we grow and develop. A typically developing person will have 23 pairs of chromosomes with one member of each pair being inherited from each parent, giving a total of 46 individual chromosomes. Two of these are the sex chromosomes which determine whether we are female (XX) or male (XY). The remaining 44 chromosomes are grouped in 22 pairs, numbered 1 to 22. The arms of a chromosome are called ‘p’ (shorter arm) and ‘q’ (long arm) (see Figure 1); these arms are separated into numerical regions, which in turn are divided into bands and sub-bands. p q Figure 1. Diagram of a chromosome Individually, rare chromosome disorders are extremely uncommon, with some being actually unique; however, collectively rare chromosome disorders make up at least one in every 200 live births, with babies either having symptoms from birth or early childhood, or being carriers of a chromosomal abnormality and experiencing the effects when they try to reproduce in later life (Searle and Hultén, 2009). Recent advances in technology and medical expertise has meant that chromosomes can be viewed at ever increasing magnifications, which is resulting in the detection of more complex defects.
  • Lab 17. Chromosomes and Karyotypes: How Do Two Physically Healthy Parents Produce a Child with Down Syndrome and a Second Child

    Lab 17. Chromosomes and Karyotypes: How Do Two Physically Healthy Parents Produce a Child with Down Syndrome and a Second Child

    Lab 17. Chromosomes and Karyotypes: How Do Two Physically Healthy Parents Produce a Child With Down Syndrome and a Second Child With Cri Du Chat Syndrome? Introduction Mendel’s model of inheritance is the basis for modern genetics. This important model can be broken down into four main ideas. First, and foremost, the fundamental unit of inheritance is the gene and alternative versions of a gene (alleles) account for the variation in inheritable characters. Second, an organism inherits two alleles for each character, one from each parent. Third, if the two alleles differ, then one is fully expressed and determines the nature of the specific trait (this version of the gene is called the dominant allele) while the other one has no noticeable effect (this version of the gene is called the recessive allele). Fourth, the two alleles for each character segregate (or separate) during gamete production. Therefore, an egg or a sperm cell only gets one of the two alleles that are present in the somatic cells of the organism. This idea is known as the law of segregation. It was brilliant (or lucky) that Mendel chose plant traits that turned out to have a relatively simple genetic basis. Each trait that he studied is determined by only one gene, and each of these genes only consists of two alleles. These conditions, however, are not met by all inheritable traits. The relationship between traits and genes is not always a simple one. In this investigation, you will use what you know about the relationship between traits and genes to explain how two children from the same family inherited two different genetic disorders.
  • Sema4 Noninvasive Prenatal Select

    Sema4 Noninvasive Prenatal Select

    Sema4 Noninvasive Prenatal Select Noninvasive prenatal testing with targeted genome counting 2 Autosomal trisomies 5 Trisomy 21 (Down syndrome) 6 Trisomy 18 (Edwards syndrome) 7 Trisomy 13 (Patau syndrome) 8 Trisomy 16 9 Trisomy 22 9 Trisomy 15 10 Sex chromosome aneuploidies 12 Monosomy X (Turner syndrome) 13 XXX (Trisomy X) 14 XXY (Klinefelter syndrome) 14 XYY 15 Microdeletions 17 22q11.2 deletion 18 1p36 deletion 20 4p16 deletion (Wolf-Hirschhorn syndrome) 20 5p15 deletion (Cri-du-chat syndrome) 22 15q11.2-q13 deletion (Angelman syndrome) 22 15q11.2-q13 deletion (Prader-Willi syndrome) 24 11q23 deletion (Jacobsen Syndrome) 25 8q24 deletion (Langer-Giedion syndrome) 26 Turnaround time 27 Specimen and shipping requirements 27 2 Noninvasive prenatal testing with targeted genome counting Sema4’s Noninvasive Prenatal Testing (NIPT)- Targeted Genome Counting analyzes genetic information of cell-free DNA (cfDNA) through a simple maternal blood draw to determine the risk for common aneuploidies, sex chromosomal abnormalities, and microdeletions, in addition to fetal gender, as early as nine weeks gestation. The test uses paired-end next-generation sequencing technology to provide higher depth across targeted regions. It also uses a laboratory-specific statistical model to help reduce false positive and false negative rates. The test can be offered to all women with singleton, twins and triplet pregnancies, including egg donor. The conditions offered are shown in below tables. For multiple gestation pregnancies, screening of three conditions
  • Trisomy 5P Inverted Duplication & Deletion of 5Pftnwdraft3

    Trisomy 5P Inverted Duplication & Deletion of 5Pftnwdraft3

    Trisomy 5p: Inverted duplication and deletion of 5p rarechromo.org Inverted duplication with deletion of 5p Inverted duplication with deletion of 5p, known as inv dup del 5p, is a very rare genetic condition in which there is an extra copy of part of the genetic material (DNA) that makes up the body’s 46 chromosomes, and a missing copy of another part. Like most other chromosome disorders, this usually affects development, and sometimes health and behaviour as well. It is likely that both the extra and missing parts of chromosome 5p have an effect, but a lot depends on their position and size. The precise effects of gaining material from a chromosome vary depending on how large the duplication is, how many genes it contains and what those genes do. The same applies to deletions. The effects may not be limited to the genes within the duplicated or deleted piece of chromosome because these genes may interact with other genes on the same chromosome or other chromosomes. Chromosomes usually come in pairs, and we inherit one chromosome from each parent. Of the 46 chromosomes, two are a pair of sex chromosomes: two Xs for a girl and an X and a Y for a boy. The remaining 44 chromosomes are grouped into 22 pairs and are numbered 1 to 22, approximately from largest to smallest. Each chromosome has a short (p) arm (from petit, the French for small) and a long (q) arm. The diagram below shows the short arm. Chromosome 5 Short (p) arm Bands Base pairs 0Mb 5Mb 10Mb 15Mb 20Mb 25Mb 30Mb 35Mb 40Mb 45Mb 48.4Mb Long (q) arm 2 People have 2 copies of chromosome 5 in most of their body cells.
  • Diseases of the Digestive System (KOO-K93)

    Diseases of the Digestive System (KOO-K93)

    CHAPTER XI Diseases of the digestive system (KOO-K93) Diseases of oral cavity, salivary glands and jaws (KOO-K14) lijell Diseases of pulp and periapical tissues 1m Dentofacial anomalies [including malocclusion] Excludes: hemifacial atrophy or hypertrophy (Q67.4) K07 .0 Major anomalies of jaw size Hyperplasia, hypoplasia: • mandibular • maxillary Macrognathism (mandibular)(maxillary) Micrognathism (mandibular)( maxillary) Excludes: acromegaly (E22.0) Robin's syndrome (087.07) K07 .1 Anomalies of jaw-cranial base relationship Asymmetry of jaw Prognathism (mandibular)( maxillary) Retrognathism (mandibular)(maxillary) K07.2 Anomalies of dental arch relationship Cross bite (anterior)(posterior) Dis to-occlusion Mesio-occlusion Midline deviation of dental arch Openbite (anterior )(posterior) Overbite (excessive): • deep • horizontal • vertical Overjet Posterior lingual occlusion of mandibular teeth 289 ICO-N A K07.3 Anomalies of tooth position Crowding Diastema Displacement of tooth or teeth Rotation Spacing, abnormal Transposition Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth K07.4 Malocclusion, unspecified K07.5 Dentofacial functional abnormalities Abnormal jaw closure Malocclusion due to: • abnormal swallowing • mouth breathing • tongue, lip or finger habits K07.6 Temporomandibular joint disorders Costen's complex or syndrome Derangement of temporomandibular joint Snapping jaw Temporomandibular joint-pain-dysfunction syndrome Excludes: current temporomandibular joint: • dislocation (S03.0) • strain (S03.4) K07.8 Other dentofacial anomalies K07.9 Dentofacial anomaly, unspecified 1m Stomatitis and related lesions K12.0 Recurrent oral aphthae Aphthous stomatitis (major)(minor) Bednar's aphthae Periadenitis mucosa necrotica recurrens Recurrent aphthous ulcer Stomatitis herpetiformis 290 DISEASES OF THE DIGESTIVE SYSTEM Diseases of oesophagus, stomach and duodenum (K20-K31) Ill Oesophagitis Abscess of oesophagus Oesophagitis: • NOS • chemical • peptic Use additional external cause code (Chapter XX), if desired, to identify cause.
  • Abstracts from the 50Th European Society of Human Genetics Conference: Electronic Posters

    Abstracts from the 50Th European Society of Human Genetics Conference: Electronic Posters

    European Journal of Human Genetics (2019) 26:820–1023 https://doi.org/10.1038/s41431-018-0248-6 ABSTRACT Abstracts from the 50th European Society of Human Genetics Conference: Electronic Posters Copenhagen, Denmark, May 27–30, 2017 Published online: 1 October 2018 © European Society of Human Genetics 2018 The ESHG 2017 marks the 50th Anniversary of the first ESHG Conference which took place in Copenhagen in 1967. Additional information about the event may be found on the conference website: https://2017.eshg.org/ Sponsorship: Publication of this supplement is sponsored by the European Society of Human Genetics. All authors were asked to address any potential bias in their abstract and to declare any competing financial interests. These disclosures are listed at the end of each abstract. Contributions of up to EUR 10 000 (ten thousand euros, or equivalent value in kind) per year per company are considered "modest". Contributions above EUR 10 000 per year are considered "significant". 1234567890();,: 1234567890();,: E-P01 Reproductive Genetics/Prenatal and fetal echocardiography. The molecular karyotyping Genetics revealed a gain in 8p11.22-p23.1 region with a size of 27.2 Mb containing 122 OMIM gene and a loss in 8p23.1- E-P01.02 p23.3 region with a size of 6.8 Mb containing 15 OMIM Prenatal diagnosis in a case of 8p inverted gene. The findings were correlated with 8p inverted dupli- duplication deletion syndrome cation deletion syndrome. Conclusion: Our study empha- sizes the importance of using additional molecular O¨. Kırbıyık, K. M. Erdog˘an, O¨.O¨zer Kaya, B. O¨zyılmaz, cytogenetic methods in clinical follow-up of complex Y.
  • Congenital Heart Disease and Chromossomopathies Detected By

    Congenital Heart Disease and Chromossomopathies Detected By

    Review Article DOI: 10.1590/0103-0582201432213213 Congenital heart disease and chromossomopathies detected by the karyotype Cardiopatias congênitas e cromossomopatias detectadas por meio do cariótipo Cardiopatías congénitas y anomalías cromosómicas detectadas mediante cariotipo Patrícia Trevisan1, Rafael Fabiano M. Rosa2, Dayane Bohn Koshiyama1, Tatiana Diehl Zen1, Giorgio Adriano Paskulin1, Paulo Ricardo G. Zen1 ABSTRACT Conclusions: Despite all the progress made in recent de- cades in the field of cytogenetic, the karyotype remains an es- Objective: To review the relationship between congenital sential tool in order to evaluate patients with congenital heart heart defects and chromosomal abnormalities detected by disease. The detailed dysmorphological physical examination the karyotype. is of great importance to indicate the need of a karyotype. Data sources: Scientific articles were searched in MED- LINE database, using the descriptors “karyotype” OR Key-words: heart defects, congenital; karyotype; Down “chromosomal” OR “chromosome” AND “heart defects, syndrome; trisomy; chromosome aberrations. congenital”. The research was limited to articles published in English from 1980 on. RESUMO Data synthesis: Congenital heart disease is characterized by an etiologically heterogeneous and not well understood Objetivo: Realizar uma revisão da literatura sobre a group of lesions. Several researchers have evaluated the pres- relação das cardiopatias congênitas com anormalidades ence of chromosomal abnormalities detected by the karyo- cromossômicas detectadas por meio do exame de cariótipo. type in patients with congenital heart disease. However, Fontes de dados: Pesquisaram-se artigos científicos no most of the articles were retrospective studies developed in portal MEDLINE, utilizando-se os descritores “karyotype” Europe and only some of the studied patients had a karyo- OR “chromosomal” OR “chromosome” AND “heart defects, type exam.
  • Cri-Du-Chat Syndrome Diagnosed in a 21-Year-Old Woman by Means of Comparative Genomic Hybridization

    Cri-Du-Chat Syndrome Diagnosed in a 21-Year-Old Woman by Means of Comparative Genomic Hybridization

    Rev. Fac. Med. 2017 Vol. 65 No. 3: 525-9 525 CASE REPORT DOI: http://dx.doi.org/10.15446/revfacmed.v65n3.57414 Cri-du-chat syndrome diagnosed in a 21-year-old woman by means of comparative genomic hybridization Síndrome de cri du chat diagnosticado en mujer de 21 años por hibridación genómica comparativa Received: 15/05/2016. Accepted: 06/08/2016. Wilmar Saldarriaga1 • Laura Collazos-Saa2 • Julián Ramírez-Cheyne2 1 Universidad del Valle - Faculty of Health - Department Morphology - MACOS Research Group - Cali - Colombia. 2 Universidad del Valle - Faculty of Health - Medicine and Surgery - Cali - Colombia. Corresponding author: Wilmar Saldarriaga. Department Morphology, Faculty of Health, Universidad del Valle. Calle 4B No. 36-00, building 116, floor 1, espacio 30. Phone number: +57 2 5285630, ext.: 4030; mobile number: +57 3164461596. Cali. Colombia. Email: [email protected]. | Abstract | entero. La prevalencia va desde 1 por 15 000 habitantes hasta 1 por 50 000 habitantes. Su diagnóstico se puede confirmar con cariotipo The cri-du-chat syndrome is caused by a deletion on the short con bandas G de alta resolución, hibridación fluorescente in situ o arm of chromosome number 5. The size of genetic material loss hibridación genómica comparativa por microarreglos (HGCm); este varies from the 5p15.2 region only to the whole arm. Prevalence se sospecha en infantes con un llanto similar al maullido de un gato, rates range between 1:15000 and 1:50000 live births. Diagnosis fascies dismórficas, hipotonía y retardo del desarrollo psicomotor; is suspected on infants with a high-pitched (cat-like) cry, facial sin embargo, en los adultos afectados los hallazgos fenotípicos son dysmorfism, hypotonia and delayed psychomotor development.
  • Author's Personal Copy

    Author's Personal Copy

    Author's personal copy 534 Z. Schlegel et al. du chromosome 5. L’atteinte oculaire chez les patients porteurs de trisomie 5 est très rare. D’après nos connaissances seulement, deux cas ont été décrits jusqu’à présent. Le cas actuel contribue à la description de la présentation oculaire en plus de phénotype clinique indéniable du syndrome de de novo trisomie partielle 5. © 2009 Elsevier Masson SAS. Tous droits réservés. Introduction Observation Trisomy of the short arm of chromosome 5 is a clinically dis- History and clinical observation cernible but very infrequent syndrome with characteristic features, considered by Stoll et al. [1] as the reverse type We describe a male Malagasy infant with a small super- of cri-du-chat syndrome. Lejeune et al. [2] first described numerary marker chromosome 5 (sSMC) present in 80% of this chromosomal abnormality in 1964; later a description metaphases. The child was born at 33 weeks gestation after was provided by Gustavson et al. [3] in 1988. The Office of in vitro fertilization and embryo transfer (IVF-ET) to the Rare Diseases (ORD) of the National Institutes of Health (NIH) 37-year-old mother with a history of sterility due to Fal- lists chromosome 5 trisomy as a ‘‘rare disease’’; this means lopian tube obstruction. The boy was born as a result of that chromosome 5 trisomy with both its subtypes, 5p and the first successful pregnancy after two unsuccessful IVF-ET 5q, affects fewer than 200,000 people in the US population. attempts with two unrelated and healthy parents. Its incidence and prevalence are difficult to establish.
  • Panorama™ Non-Invasive Prenatal Screening for Microdeletion Syndromes

    Panorama™ Non-Invasive Prenatal Screening for Microdeletion Syndromes

    NON-INVASIVE PRENATAL SCREENING FOR MICRODELETION SYNDROMES HALL 1 PANORAMA™ NON-INVASIVE PRENATAL SCREENING FOR MICRODELETION SYNDROMES MEGAN P. HALL, PH.D. INTRODUCTION PanoramaTM is a non-invasive prenatal screening test for fetal chromosomal anomalies. The screening test analyzes fetal cell-free DNA (cfDNA) isolated from maternal plasma and can be performed as early as 9 weeks of gestation with high accuracy. Panorama was originally designed to screen for Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau syndrome), Monosomy X (Turner syndrome), sex chromosome trisomies, triploidy and, if requested, fetal sex (1-5). Recently, the clinical scope of Panorama was expanded to include screening for five microdeletion syndromes. This Panorama Extended Panel now screens for the 22q11.2 deletion (DiGeorge), 1p36 deletion, Cri-du-chat, Prader-Willi, and Angelman deletions. Validation studies have demonstrated sensitivities of greater than 93% and specificities of greater than 99% for each microdeletion condition. MICRODELETION PREVALENCE AND TRADITIONAL MICRODELETION DETECTION Clinically relevant microdeletions and microduplications are more common than previously thought, occurring in up to 1 in 60 pregnancies, and can occur in pregnancies lacking ultrasound anomalies (6). The combined at-birth incidence of the 5 microdeletion syndromes covered by this screening test is approximately 1 in 1,000 (7-11), approaching the overall rate observed for Down syndrome (12). The most common microdeletion, 22q11.2 deletion, is more common than Edwards syndrome and Patau syndrome combined, and is more common than cystic fibrosis (Figure 1)(10,12,13). Further, the risk for microdeletions is independent of maternal age, unlike whole chromosome aneuploidies like Trisomy 21 (Down syndrome) that are more prevalent in women of advanced maternal age.
  • Ring Chromosome 5 with Dental Anomalies

    Ring Chromosome 5 with Dental Anomalies

    PEDIATRICDENTISTRY/Copyright -~ 1981 by The American Academyof Pedodontics/Vol. 3, No. 4 CASE Ring chromosome 5 with dental anomalies Katherine Kula, DMDShivanand Patil, PhD James Hanson, MD Arthur Nowak, DMDHans Zellweger, MD Abstract Although ring chromosomesare observed in ahnost all manent molars is reported in one case2 autosomalgroups in man, they are rare. Wedescribe a male Although,~ some patients survive to adulthood) patient exldbiting cd du chat syndromein which most patients die in infancy due to severe respiratory cytogenetic studies demonstratethe presonse of a ring and feeding problems2 chromosome5. Deletion o£ the ring chromosome5 is found between the p15 and q35 bands. Dental, medical and Diagnosis is based on clinical features, abnormal cytogenetic findings are comparedto other ring chromosome crying during infancy, chromosomal studies, and der- 5 cases descMbedin literature. matoglyphic features. Diagnosis based soley on clini- cal features is difficult in somecases due to phenoty- Introduetion pic variability and to characteristics changing with Cri du chat syndrome, first described in 1963,~ is age. Clinical features are used, however, as indications characterized by a shrill high cry similar to that of a for confLrmatory chromosomal studiesY young cat. The cry is attributed to a hypotonic, dys- Cri du chat syndromeis usually attributed to a par- morphic larynx noted in some patients. ~ The cry may tial deletion, either terminal or interstitial, of the not be pathognomonic of the syndrome since it is ab- short arm of chromosome57 in the area of p14 to p15 sent in some patients and is reported in other chromo- band?~ The most commonly reported cause is de novo somal abnormalities? deletion occurring in approximately 85 percent of the The~,~ following traits may be found during infancy: cases, m~There are eight reported cases of ring chromo- microcephaly, round facies, apparent ocular hypertel- someu,l~ 5.
  • Neurological Syndromes

    Neurological Syndromes

    Neurological Syndromes J. Gordon Millichap Neurological Syndromes A Clinical Guide to Symptoms and Diagnosis J. Gordon Millichap, MD., FRCP Professor Emeritus of Pediatrics and Neurology Northwestern University Feinberg School of Medicine Chicago, IL, USA Pediatric Neurologist Ann & Robert H. Lurie Children’s Hospital of Chicago Chicago , IL , USA ISBN 978-1-4614-7785-3 ISBN 978-1-4614-7786-0 (eBook) DOI 10.1007/978-1-4614-7786-0 Springer New York Heidelberg Dordrecht London Library of Congress Control Number: 2013943276 © Springer Science+Business Media New York 2013 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi lms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifi cally for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher’s location, in its current version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law. The use of general descriptive names, registered names, trademarks, service marks, etc.